openPR Logo
Press release

Asia-Pacific Anticoagulants Market: Analysis Report, Share, Trends and Overview 2021-2027

10-23-2021 02:57 PM CET | Health & Medicine

Press release from: Orion Market Research

Asia-Pacific anticoagulants market is estimated to grow at a CAGR of 7.8% during the forecast period. Researchers from the National Center for CVD in China have examined the prevalence and treatment of increased CVD risk in 1.7 million people from the China PEACE Million Persons Project. It is a Chinese government-funded project being conducted during 2014–2015 across four provinces in the country for CVD screening and management. Of approximately 1.7 million participants with the age group of 35-75 years, 9.5% had an increased risk for CVD. This results in an increasing CVD incidence in the region, which is driving the adoption of anticoagulants in the country.

A full report of Asia-Pacific Anticoagulants Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-anticoagulants-market

A vitamin K antagonist is utilized for the treatment of thromboembolism with cardiac valve replacement, thromboembolic events post-myocardial infarction, venous thromboembolism, pulmonary embolism, and thromboembolism with atrial fibrillation. In vitamin K antagonist (VKA) anticoagulant, warfarin is the most commonly utilized medication to reduce the risk of stroke in certain atrial fibrillation patients with risk factors. Additionally, NOACs are the ideal suggested drug class compared to warfarin, except for patients suffering from moderate to severe mitral stenosis or an artificial heart valve. NOACs comprises edoxaban, dabigatran, apixaban, and rivaroxaban.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-anticoagulants-market

Scope of the Asia-Pacific Anticoagulants Market

Market Coverage

• Market number available for 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Type and Application
• Regions Covered- China, India, Japan, and Rest of Asia-Pacific
• Competitive Landscape- Cipla Ltd., Bristol Myers Squibb Co., Pfizer Inc., Daiichi Sankyo Co. Ltd., and Boehringer Ingelheim GmbH

Recent Strategic Initiatives in the Asia-Pacific Anticoagulants Market

• In June 2020, Gland Pharma Ltd. along with its partners Athenex Pharmaceutical Division and MAIA Pharmaceuticals Inc declared the introduction of a ready-to-use Bivalirudin injection in the US. This injection is intended for use as an anticoagulant among patients who are experiencing percutaneous coronary intervention (PCI), which includes patients suffering from heparin-induced thrombocytopenia and thrombosis syndrome, and heparin-induced thrombocytopenia.
• In October 2019, Morepen Labs has added three new drugs, including UDCA (for liver ailments), Rivaroxaban (cardiac segment), and Vildagliptin (diabetes segment) to its active pharmaceutical ingredients (API) portfolio. Rivaroxaban is an anticoagulant which is a blood thinner.

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID-19forecast
o Most affected segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Anticoagulants Market-Segmentation

By Type

• Novel Oral Anticoagulants (NOACs)
• Vitamin K Antagonist
• Heparin and Low Molecular Weight Heparin (LMWH)

By Application

• Pulmonary Embolism
• Atrial Fibrillation/Myocardial Infarction (Heart Attack)
• Deep Vein Thrombosis (DVT)
• Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-anticoagulants-market

Asia-Pacific Anticoagulants Market– Segment by Country

• China
• India
• Japan
• Rest of Asia-Pacific

Company Profiles

• AstraZeneca plc
• Bristol Myers Squibb Co.
• Cipla Ltd.
• Daiichi Sankyo Company, Ltd.
• Dr. Reddy's Laboratories
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Novartis International AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific Anticoagulants Market: Analysis Report, Share, Trends and Overview 2021-2027 here

News-ID: 2439068 • Views: 317

More Releases from Orion Market Research

Germany Active Insulation Market Report 2021: By Key Players, Application, Size, …
Germany active insulation market is estimated to grow at a CAGR of 5.0% during the forecast period. As per the Destatis, turnover in the main construction industry increased by 11.0% in June 2020 compared to June 2019. This leads to increasing demand for active insulation products in the building and construction sector to reduce CO2 emissions and boost energy savings. Despite the COVID 19 pandemic, the German government continued its
European Active Insulation Market Size, Share, Impressive Industry Growth, Repor …
Europe active insulation market is estimated to grow at a CAGR of 4.8% during the forecast period. The rising demand for sportswear is accelerating the demand for active insulation products in the region. In Europe, sportswear is rising strongly owing to the increasing trend towards more active and healthier lifestyles in all age groups. In Europe, fashion Sportswear is regarded as the major category in the Sportswear segment. UK, Germany,
Global DDI (DNS, DHCP and IP Address Management) Market Size, Industry Trends, S …
The DDI is a combination of DNS, DHCP, and IP Address Management (IPAM) solutions. These solutions significantly deliver quick and efficient management initiatives of numerous tasks, for DNS and DHCP service management and internet protocol address management over the internet network. The DNS, DHCP, and IP Address Management solutions serve as the dominant tools for management operations among various enterprises. The Global DDI (DNS, DHCP, and IP Address Management)
Asia-Pacific Active Insulation Market Size, Share, Impressive Industry Growth, R …
Asia-Pacific Active Insulation Market is estimated to grow at a CAGR of 6.8% during the forecast period. The increasing trend towards smart city projects is expected to offer an opportunity for the adoption of green insulation materials. As per the German Asia-Pacific Business Association, the Government of China is highly engaged in the smart cities’ development and approximately 500 pilot projects have already been running in the country. Further, in

All 5 Releases


More Releases for Anticoagulants

Anticoagulants Market: Emergence of Novel Oral Anticoagulants Reduces Health Car …
Anticoagulants have been the mainstay of therapy for the long-term and acute prevention and treatment of various types of thromboembolic disorders. The prevention of thromboembolic stroke among patients with persistent atrial fibrillation (AF) has been one of the main indications for oral anticoagulation therapy. At least 2.6 million people are living with atrial fibrillation, and it is estimated to reach 12 million people by the year 2050, states American Heath
Global Anticoagulants Market 2018-2022 Edition | ResearchByMarkets
"Global Anticoagulants Market (2018-2022 Edition)" Bayer, BMS/Pfizer, Boehringher Ingelheim and Daiichi Sankyo are some of the key players operating in the global anticoagulants market, whose company profiling has been done in the report. This segment summarizes business overview, financial overview and the business strategies of the companies. More Information: https://www.researchbymarkets.com/report/global-anticoagulants-market-2018-2022-edition-15196.html This report provides an in-depth analysis of the global anticoagulants market with description of market size and growth. The analysis include market share
Advent of Advanced Oral Anticoagulants Drugs To Propel Global and United States …
Anticoagulants are also known as antithrombotic drugs, which help prevent the formation of blood clot or thrombus. These drugs are used to lessen the formation of clot by reducing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are several types of elements that help in clotting process. Venous thrombosis and arterial thrombosis are both treated with anticoagulant drugs. Marketresearchreports.biz recently published report, titled, “2018-2025 Anticoagulants
Burgeoning Geriatric Population Driving Global Anticoagulants Market
"The Report Global Anticoagulants Market: Size, Trends & Forecasts (2017-2021) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" MarketResearchReports.biz has announced the addition of the report titled, “Global Anticoagulants Market: Size, Trends & Forecasts 2017 - 2021,” to their offering. The report furnishes crucial information about the market such as its size, the competitive landscape, and its growth prospects going forward.
Injectable Anticoagulants Market Share & Forecasts Research Report to 2022
Injectable Anticoagulants market get comprehensive research offering detailed regional analysis and growth outlook in a new report now available at MarketSizeForecasters.com "The Injectable Anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin], enoxaparin [Lovenox]) and factor Xa inhibitors (fondaparinux [Arixtra]). In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism." Request a sample copy of Injectable Anticoagulants Market Research Report @ https://marketsizeforecasters.com/get-sample/14599 Scope of
Global Anticoagulants Market Size, Trends & Forecasts (2016-2020)
The report entitled Global Anticoagulants Market: Size, Trends & Forecasts (2016-2020) provides an analysis of the global anticoagulants market with detailed description of market size & growth and market share by products. The report also provides a detailed analysis of anticoagulants available in the market. Details of Lovenox, Arixtra, Fraxiparine (injectable anticoagulants), Xarelto, Pradaxa and Eliquis (NOACs) has provided in terms of their worldwide sales. The report provides detailed regional analysis of